Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Akums Pharma’s IPO to open on July 30, 2024
Price Band fixed at ₹ 646 to ₹ 679 per equity share of face value of ₹ 2 each
Zydus gets COFEPRIS nod to market Bhava to treat various cancers
Bhava, a Bevacizumab biosimilar and will be marketed in different strengths of 100 mg/4 ml and 400 mg/16 ml
Medicamen invests $75,000 in Rwanda, expands East African presence
Medicamen plans to establish its warehouse and depot in Kigali, Rwanda
Centaur launches chronic heart failure generic drug In the US
Introduces generic Ivabradine hydrochloride, expanding its US market presence
Spinal muscular atrophy market across 7MM to grow to $3 billion by 2033, forecasts GlobalData
Key drivers include Myostatin inhibitors and label expansions, despite impending Spinraza patent expirations
Mankind Pharma signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan…
The agreement allows Mankind Pharma to launch the novel drug for treating GERD under its trademark
Prioritised investments from pharma companies shaping competitive pipeline landscape of…
In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritising their…
Emcure makes a premium of 31.5 per cent over IPO price
Emcure's IPO ran from July 3 to July 5 and is a book-built issue valued at Rs 1,952.03 crores
Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
Industry reports 76 deals worth $5B in June 2023: GlobalData
The pharma industry reported 88 VC deals worth $2.5B in June 2024, compared to the last 12-month (June 2023 to May 2024) average…
Submission of Nidlegy marketing authorisation application validated by EMA
The first marketing authorisation application of Nidlegy for the treatment of locally advanced fully resectable melanoma was…
Emcure Pharmaceuticals secures ₹582 crore from anchor investors
Investment comes at the upper price band of Rs. 1008 per share ahead of IPO opening
Amylyx looks to cover financial gap left by Relyvrio with avexitide deal, says GlobalData
The acquisition is a strategic action by Amylyx following the failure of its lead amyotrophic lateral sclerosis (ALS) therapy,…
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base:…
Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative
Ayurveda market anticipated to hit $25 bn with international exports, says Dr Manoj Nesari
Exports are being made, particularly to the EU, UAE, and Japan, while other markets like Malaysia, Southeast Asia, and Taiwan are…
Alzheimer’s drug Leqembi launched by Eisai, Biogen in China
China is the third country to launch LEQEMBI following the US and Japan
Osteoporosis market to reach $17.9 bn across 7MM in 2033: GlobalData
With longer lifespans, its prevalence is expected to rise, necessitating a greater focus on bone health management and proactive…
FDA approval of CAPVAXIVE will enhance protection against pneumococcal disease in older adults:…
This is the first pneumococcal vaccine that is specifically designed to protect against serotypes which particularly infect older…
Dr Reddy’s to acquire Nicotinell and related portfolio
The portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol…